Literature DB >> 8268576

Emergency lung transplantation after extracorporeal membrane oxygenation.

M J Jurmann1, H J Schaefers, S Demertzis, A Haverich, T Wahlers, H G Borst.   

Abstract

In some patients with acute respiratory failure, the native lungs do not recover during extracorporeal membrane oxygenation (ECMO), or complications occur that preclude the meaningful continuation of ECMO therapy. In such cases, emergency lung transplantation (LTx) represents the only therapeutic alternative. Between May 1988 and April 1993, the authors have performed LTx after ECMO support in five of 111 lung or heart-lung transplantations (4.5%). Two patients presented with early graft failure after unilateral LTx. In these patients, ECMO was used as a bridging device to unilateral re-LTx for 1, resp. 11 days. One patient died 6 months post-operatively from chronic rejection; the other underwent a third LTx and is doing well after 42 months. In three further patients already treated with ECMO for 5 to 12 days for ARDS (n = 2) or acute respiratory failure after liver and kidney transplantation, the native lungs did not recover (n = 2) or pulmonary hemorrhage developed. The last patient (unilateral LTx) and one of the former (bilateral LTx for ARDS) are long-term survivors (12, 30 months). The remaining patient (unilateral LTx for ARDS) had severe multiorgan failure at the time of his operation and died intraoperatively. The authors conclude that ECMO no longer represents a contraindication to subsequent LTx. Their results also support the continued investigation of this combined therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268576     DOI: 10.1097/00002480-199307000-00059

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  3 in total

1.  Long- and short-term clinical impact of awake extracorporeal membrane oxygenation as bridging therapy for lung transplantation.

Authors:  Nam Eun Kim; Ala Woo; Song Yee Kim; Ah Young Leem; Youngmok Park; Se Hyun Kwak; Seung Hyun Yong; Kyungsoo Chung; Moo Suk Park; Young Sam Kim; Ha Eun Kim; Jin Gu Lee; Hyo Chae Paik; Su Hwan Lee
Journal:  Respir Res       Date:  2021-11-28

2.  Lung transplantation for the treatment of irreversible acute respiratory distress syndrome.

Authors:  Takashi Harano; John P Ryan; Ernest G Chan; Kentaro Noda; Matthew R Morrell; James D Luketich; Pablo G Sanchez
Journal:  Clin Transplant       Date:  2020-12-15       Impact factor: 3.456

3.  Lung transplantation for acute respiratory distress syndrome: A multicenter experience.

Authors:  Anna E Frick; Christiaan T Gan; Robin Vos; Stefan Schwarz; Felix Kraft; Daria Kifjak; Arne P Neyrinck; Dirk E Van Raemdonck; Walter Klepetko; Peter Jaksch; Erik A M Verschuuren; Konrad Hoetzenecker
Journal:  Am J Transplant       Date:  2021-07-24       Impact factor: 9.369

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.